Viewing Study NCT01114503

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 7:12 PM

Ignite Modification Date: 2026-02-28 @ 5:31 AM

Study NCT ID: NCT01114503

Status: TERMINATED

Last Update Posted: 2020-10-30

First Post: 2010-04-29

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease

Sponsor: GlaxoSmithKline

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module